The Prediction of Malignant Cerebral Infarction by Molecular Brain Barrier Disruption Markers
- 1 September 2005
- journal article
- clinical trial
- Published by Ovid Technologies (Wolters Kluwer Health) in Stroke
- Vol. 36 (9), 1921-1926
- https://doi.org/10.1161/01.str.0000177870.14967.94
Abstract
Background and Purpose— Space-occupying brain edema is a life-threatening complication in patients with large hemispheric stroke. The aim of the study was to determine whether molecular markers of endothelial damage may help to predict secondary brain edema and, secondly, to identify patients who could benefit from aggressive therapies such as decompressive hemicraniectomy or hypothermia. Methods— We studied 40 consecutive patients with malignant middle cerebral artery (MCA) infarction and 35 controls with massive MCA infarctions Results— Mean time from stroke onset to blood sampling was 6.3±4.8 in m-MCA and 7.7±6.0 hours in the control group ( P =0.63). Baseline characteristics were comparable in both groups. c-Fn and MMP-9 levels were significantly higher in patients with m-MCA than in controls (all P 16.6 μg/mL had the highest sensitivity (90%), specificity (100%), and negative and positive predictive values (89% and 100%, respectively) for the prediction of m-MCA infarction. Conclusions— A plasma c-Fn concentration >16.6 μg/mL at admission is associated with the development of m-MCA infarction with high sensitivity and specificity, suggesting that c-Fn might be useful in therapeutic decision making.This publication has 17 references indexed in Scilit:
- Plasma Cellular-Fibronectin Concentration Predicts Hemorrhagic Transformation After Thrombolytic Therapy in Acute Ischemic StrokeStroke, 2004
- Prediction of Malignant Course in MCA Infarction by PET and MicrodialysisStroke, 2003
- Prediction of Malignant Middle Cerebral Artery Infarction by Early Perfusion- and Diffusion-Weighted Magnetic Resonance ImagingStroke, 2003
- Matrix Metalloproteinases Increase Very Early during Experimental Focal Cerebral IschemiaJournal of Cerebral Blood Flow & Metabolism, 1999
- Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/ReperfusionJournal of Cerebral Blood Flow & Metabolism, 1996
- Proteolytic Cascade Enzymes Increase in Focal Cerebral Ischemia in RatJournal of Cerebral Blood Flow & Metabolism, 1996
- Extracellular Matrix‐Degrading Proteinases in the Nervous SystemBrain Pathology, 1994
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Formulas for threshold computationsComputers and Biomedical Research, 1991
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991